These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16988659)

  • 41. Gene therapy rising?
    Hoag H
    Nature; 2005 May; 435(7041):530-1. PubMed ID: 15917820
    [No Abstract]   [Full Text] [Related]  

  • 42. Gene therapy in the clinic: whose risks?
    Ashcroft RE
    Trends Biotechnol; 2004 Nov; 22(11):560-3. PubMed ID: 15491799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene therapy advances but struggles to interpret safety data in small animal models.
    Williams DA
    Mol Ther; 2006 Jun; 13(6):1027-8. PubMed ID: 16684622
    [No Abstract]   [Full Text] [Related]  

  • 44. Visible integration of the adenosine deaminase (ADA) gene into the recipient genome after gene therapy.
    Egashira M; Ariga T; Kawamura N; Miyoshi O; Niikawa N; Sakiyama Y
    Am J Med Genet; 1998 Jan; 75(3):314-7. PubMed ID: 9475605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. American Society of Gene Therapy meeting. Retroviral vectors: a double-edged sword.
    Kaiser J
    Science; 2005 Jun; 308(5729):1735-6. PubMed ID: 15961648
    [No Abstract]   [Full Text] [Related]  

  • 46. Gene therapy: shining hopes dented - but not dashed.
    Check E
    Nature; 2002 Dec 19-26; 420(6917):735. PubMed ID: 12490910
    [No Abstract]   [Full Text] [Related]  

  • 47. Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold.
    Buchholz CJ; Cichutek K
    J Gene Med; 2006 Oct; 8(10):1274-6. PubMed ID: 17001625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A third tumor following SCID gene therapy].
    Winckler T
    Pharm Unserer Zeit; 2005; 34(3):184-5. PubMed ID: 15940949
    [No Abstract]   [Full Text] [Related]  

  • 49. Gene therapy. RAC's advice: proceed with caution.
    Kaiser J
    Science; 2002 Dec; 298(5601):2113-5. PubMed ID: 12481114
    [No Abstract]   [Full Text] [Related]  

  • 50. Bubble babies and bathwater.
    Nat Biotechnol; 2002 Nov; 20(11):1063. PubMed ID: 12410236
    [No Abstract]   [Full Text] [Related]  

  • 51. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
    Puck JM; Deschênes SM; Porter JC; Dutra AS; Brown CJ; Willard HF; Henthorn PS
    Hum Mol Genet; 1993 Aug; 2(8):1099-104. PubMed ID: 8401490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Too high a cost for a cure?
    Boyce N
    US News World Rep; 2002 Oct; 133(14):34. PubMed ID: 12389521
    [No Abstract]   [Full Text] [Related]  

  • 54. [Gene therapy in primary immunologic failure].
    Frøland SS
    Tidsskr Nor Laegeforen; 2001 Jan; 121(3):351-4. PubMed ID: 11242882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency.
    Puck JM; Pepper AE; Henthorn PS; Candotti F; Isakov J; Whitwam T; Conley ME; Fischer RE; Rosenblatt HM; Small TN; Buckley RH
    Blood; 1997 Mar; 89(6):1968-77. PubMed ID: 9058718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safeguards for gene therapy trials.
    FDA Consum; 2003; 37(3):5. PubMed ID: 12793378
    [No Abstract]   [Full Text] [Related]  

  • 57. Insertional oncogenesis in gene therapy: how much of a risk?
    Sadelain M
    Gene Ther; 2004 Apr; 11(7):569-73. PubMed ID: 15029226
    [No Abstract]   [Full Text] [Related]  

  • 58. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Cavazzana-Calvo M
    Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene therapy. RAC hears a plea for resuming trials, despite cancer risk.
    Kaiser J
    Science; 2003 Feb; 299(5609):991. PubMed ID: 12586909
    [No Abstract]   [Full Text] [Related]  

  • 60. Gene therapy: beyond 2000.
    Verma IM
    Mol Ther; 2000 Jun; 1(6):493. PubMed ID: 10933971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.